InvestorsHub Logo
Followers 16
Posts 1568
Boards Moderated 0
Alias Born 12/13/2009

Re: georgejjl post# 399846

Wednesday, 01/25/2023 12:10:18 AM

Wednesday, January 25, 2023 12:10:18 AM

Post# of 463810

On average, patients, who were taking 50 mg/day of blarcamesine, improved their ADAS-Cog cognition score much much better than -4.03 points.



Provide a link to that high dose cohort Cog improvement as reported by AVXL. If you can't, it's not a FACT!!!

By the way, what was the AVXL ADAS-Cog score for ALL treated patients, including the ones that showed no improvement? Strange that AVXL did not report that number.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News